Assessment of the potential public health impact of Herpes Zoster vaccination in Germany

Assessment of the potential public health impact of Herpes Zoster vaccination in Germany

The aim of this study was to compare the public health impact of introducing 2 Herpes Zoster (HZ) vaccines, Zoster Vaccine Live (ZVL) versus a non-live adjuvanted subunit candidate vaccine (HZ/su), in the German population aged 50+ years split into 3 age cohorts, i.e. 50–59, 60–69 and 70+ years, res...

Full description

Bibliographic Details
Main Authors: Desmond Curran, Desirée Van Oorschot, Lijoy Varghese, Lidia Oostvogels, Tomas Mrkvan, Romulo Colindres, Alfred von Krempelhuber, Anastassia Anastassopoulou
Format: Article
Language:English
Published: Taylor & Francis Group 2017-10-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
herpes zoster
public health impact
vaccination
number needed to vaccinate
Online Access:http://dx.doi.org/10.1080/21645515.2017.1345399

Internet

http://dx.doi.org/10.1080/21645515.2017.1345399

Similar Items